Cutaneous T-cell lymphoma-like drug eruption in an HIV-positive patient taking vancomycin and rifampin

J Cutan Med Surg. 2013 Nov-Dec;17(6):433-6. doi: 10.2310/7750.2013.13047.

Abstract

Background: Cutaneous T-cell pseudolymphoma (CTPL) is a benign reactive T-cell lymphoproliferative subtype of pseudolymphoma. Some variants of CTPL can resemble the plaques of mycosis fungoides (MF). The vast majority of drug-induced cases have been associated with anticonvulsants. There is only one report in the literature documenting a case of vancomycin-induced CTPL.

Methods: We report a cutaneous T-cell lymphoma-like eruption in a human immunodeficiency virus (HIV)-positive patient recently started on vancomycin and rifampin.

Results: A skin biopsy showed several histologic features of MF with immunohistochemical and T-cell receptor gene rearrangement studies suggestive of CTPL. This atypical T-cell reaction mimicking MF completely resolved on cessation of rifampin followed by vancomycin.

Conclusion: Considering drug-induced causes of MF-like histologic changes is crucial to prevent unnecessary treatment for MF.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Biopsy
  • Diagnosis, Differential
  • Drug Eruptions / diagnosis
  • Drug Eruptions / etiology*
  • Drug Therapy, Combination / adverse effects
  • Enzyme Inhibitors / adverse effects
  • Female
  • HIV Seropositivity / complications*
  • HIV Seropositivity / drug therapy
  • Humans
  • Lymphoma, T-Cell, Cutaneous / chemically induced*
  • Lymphoma, T-Cell, Cutaneous / diagnosis
  • Rifampin / adverse effects*
  • Skin / pathology*
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / diagnosis
  • Vancomycin / adverse effects*
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Enzyme Inhibitors
  • Vancomycin
  • Rifampin